Heartland Advisors Inc. Purchases New Stake in Innovex International, Inc. $INVX
Heartland Advisors Inc. has acquired a new stake in Innovex International, Inc. (NYSE: INVX), purchasing 200,000 shares worth approximately $3.71 million in Q3. This move by Heartland Advisors contributes to a broader trend of hedge funds adjusting their positions in Innovex International. The company currently holds a "Moderate Buy" consensus rating from analysts, with insider selling also noted recently from its CEO and another insider.
Innovex International, Inc. Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Innovex International, Inc. (NYSE: INVX) announced it will release its fourth quarter and full year 2025 earnings results on February 23, 2026, after market close. The company will also host a conference call and webcast on February 24, 2026, at 9:00 a.m. Eastern Time to discuss these results. Details for accessing the call and a replay are provided.
Innovex International, Inc. Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Innovex International, Inc. has scheduled its Fourth Quarter and Full Year 2025 Earnings Release and Conference Call. The article also mentions Unity Software's Q4 earnings, reporting a 35% year-over-year revenue increase to $609 million, exceeding estimates, despite a quarterly loss of 66 cents per share. This financial news provides updates on corporate reporting and performance.
Innovex International (INVX) is a Great Momentum Stock: Should You Buy?
Innovex International (INVX) has been identified as a strong momentum stock, earning a "B" on the Zacks Momentum Style Score and a Zacks Rank #2 (Buy). This assessment is based on its recent price performance, which has significantly outpaced its industry and the S&P 500, and positive earnings estimate revisions. Investors are advised to consider INVX as a potential pick for short-term gains.
Acuitas Investments LLC Has $69,000 Stock Position in Innovex International, Inc. $INVX
Acuitas Investments LLC significantly reduced its stake in Innovex International, Inc. (NYSE: INVX) by 98.0% in Q3, now holding 3,700 shares valued at approximately $69,000. Despite this reduction, analyst sentiment remains positive with a "Moderate Buy" consensus and a price target of $20.00, while insider selling by the CEO and another insider recently occurred, though insiders still own 43.90% of the company.
Innovex International stock hits 52-week high at 25.16 USD By Investing.com
Innovex International's stock reached a new 52-week high of $25.16, currently trading at $25.65 with a market capitalization of $1.72 billion. The company has demonstrated robust performance, boasting a 1-year price return of 41.12% and a great financial health score. This surge follows strong third-quarter 2025 earnings, where EPS and revenue significantly surpassed analyst expectations.
Innovex International stock hits 52-week high at 25.16 USD
Innovex International Inc. has reached a new 52-week high of $25.16 USD, with its stock currently trading at $25.65 and a market capitalization of $1.72 billion. This surge is supported by a 1-year price return of 41.12% and a "GREAT" financial health score of 3.48 from InvestingPro, indicating strong financial performance. The company also reported impressive Q3 2025 earnings, surpassing analyst expectations with an EPS of $0.57 and revenue of $240 million.
Innovex International stock hits 52-week high at 25.16 USD By Investing.com
Innovex International Inc. (INVX) stock has reached a new 52-week high of $25.16 USD, currently trading at $25.65 with a market capitalization of $1.72 billion. The company has demonstrated strong financial health with a 41.12% one-year price return and a 58.18% six-month return, coupled with a robust current ratio of 4.78. This performance follows impressive third-quarter 2025 earnings, where EPS and revenue significantly surpassed analyst expectations.
Innovex International stock hits 52-week high at 25.16 USD By Investing.com
Innovex International Inc. (INVX) stock has reached a new 52-week high of $25.16 USD, currently trading at $25.65 with a market capitalization of $1.72 billion. The company has demonstrated strong financial health with a 41.12% one-year price return and a 58.18% six-month return, backed by a great financial health score of 3.48 and a high current ratio of 4.78. This performance follows impressive Q3 2025 earnings, where EPS nearly doubled expectations and revenue exceeded projections, reinforcing investor confidence and strategic market positioning.
The Bull Case For Innovex International (INVX) Could Change Following Upbeat Earnings Revisions And Momentum Score Upgrade
Innovex International (INVX) has seen its investment outlook improve due to upbeat earnings revisions, a B-grade Momentum Style Score, and a Zacks Rank of #2 (Buy). While the company has shown strong revenue growth, it has struggled with consistent high-margin profitability, but recent operational delivery has shifted market sentiment positively. Investors are now focused on management's ability to maintain this improved sentiment, manage governance, and sustain profit margins, especially given a wide range of fair value estimates.
Insider Transaction: Mark Reddout Sells $500K Worth Of Innovex International Shares
Mark Reddout, President North America at Innovex International (NYSE: INVX), recently sold 20,000 shares of the company's stock for a total value of $500,000, as disclosed in an SEC Form 4 filing. This transaction occurred on January 15, and Innovex International's shares were trading at $24.31, experiencing a slight downtick. The article also provides a financial overview of Innovex International, highlighting its strong revenue growth, gross margin, EPS, and moderate debt, while noting its stock's premium P/E and P/S ratios and potentially undervalued EV/EBITDA.
Innovex International Chief Executive Officer Sold $331K In Company Stock
Adam Anderson, CEO of Innovex International (NYSE: INVX), sold 13,241 company shares worth $331,025 on January 15, according to an SEC filing. This article details Innovex International's financial performance, including a 58.09% revenue growth and strong profitability metrics, alongside an analysis of its valuation. It also explains the significance and types of insider transactions.
Insider Sell Alert: CEO Adam Anderson Sells Shares of Innovex In
Adam Anderson, CEO of Innovex International Inc (INVX), sold 13,241 shares on January 14, 2026, reducing his total holdings to 498,822 shares. This transaction follows a pattern of insider selling, with no insider purchases reported for INVX in the past year. The company's stock was trading at $25 per share, with a market capitalization of $1.675 billion and a P/E ratio of 16.54, which is higher than the industry median.
Insider Selling: Innovex International (NYSE:INVX) Insider Sells 20,000 Shares of Stock
Mark Reddout, an insider at Innovex International (NYSE:INVX), sold 20,000 shares of the company's stock for $500,000 on January 14th, reducing his ownership by 13.38%. The stock traded at $24.30 following the sale, with a market capitalization of $1.67 billion and a P/E ratio of 16.53. Analyst sentiment for Innovex International is generally positive, with a "Moderate Buy" consensus rating and a price target raise by Piper Sandler to $27.
Innovex International president sells $500,000 in shares
Mark Reddout, President of North America at Innovex International, sold 20,000 shares of company stock for $500,000 on January 14, 2026. This transaction was executed under a Rule 10b5-1 plan, leaving him with 129,436 shares. The sale follows Innovex International's strong third-quarter 2025 earnings, where the company significantly exceeded analyst expectations for both EPS and revenue.
Anderson Adam, Innovex CEO, sells $331k in shares
Innovex International CEO Adam Anderson sold 13,241 shares of company stock for $331,025 on January 14, 2026, under a pre-arranged trading plan. This transaction leaves him with 498,822 shares. The sale follows Innovex's strong third-quarter 2025 earnings, where the company significantly exceeded analyst expectations for both EPS and revenue.
Innovex International (NYSE:INVX) CEO Sells $331,025.00 in Stock
Innovex International CEO Adam Anderson sold 13,241 shares of company stock for $331,025 on January 14th, reducing his stake by 2.59%. The company's stock traded up 0.1% to $24.30, with a market cap of $1.67 billion. Analysts maintain a "Moderate Buy" rating, and institutional investors have recently increased their holdings in INVX.
Innovex International stock reaches 52-week high at 24.38 USD By Investing.com
Innovex International Inc. has reached a 52-week high of $24.38 USD, demonstrating a 49.59% total return over the past year and a 45.43% gain in the last six months. This performance is supported by strong financials, including $955.34 million in revenue and $1.32 in diluted earnings per share, with recent Q3 2025 earnings significantly surpassing analyst expectations. The company maintains a "GREAT" financial health score and is considered slightly undervalued, attracting investor attention.
Innovex International stock reaches 52-week high at 24.38 USD
Innovex International Inc. (INVX) has reached a new 52-week high of $24.38, reflecting a significant 49.59% total return over the past year and a 45.43% gain in the last six months. This surge is supported by strong financials, including $955.34 million in revenue and $1.32 diluted EPS, and an "outstanding" financial health score, indicating strong investor confidence. The company also recently reported Q3 2025 earnings that significantly surpassed analyst expectations, with an EPS of $0.57 against a forecasted $0.29 and revenue of $240 million.
Innovex International stock reaches 52-week high at 24.38 USD
Innovex International Inc. (INVX) stock has reached a 52-week high of $24.38 USD. This surge reflects strong investor confidence due to impressive financials, including $955.34 million in revenue and $1.32 in diluted EPS over the last twelve months, and a "GREAT" overall financial health score according to InvestingPro. The company also recently reported Q3 2025 earnings that significantly surpassed analyst expectations, further boosting investor interest.
Innovex International, Inc. (NYSE:INVX) Given Average Recommendation of "Buy" by Brokerages
Brokerage firms have given Innovex International, Inc. (NYSE:INVX) an average "Buy" rating, with a mean one-year price target of $20.00. Institutional investors have significantly increased their stakes in the company, with Wellington Management Group LLP boosting its position by over 50% and Brandes Investment Partners LP holding a substantial number of shares. Innovex International trades near its 52-week high, boasts a market capitalization of $1.62 billion, and has reported a net margin of 10.59% in its last quarter.
Innovex International stock hits 52-week high at $24.32 By Investing.com
Innovex International Inc.'s stock reached a new 52-week high of $24.32, marking a significant milestone for the $1.66 billion market cap company with a 53.09% total return over the past year. This performance is supported by strong financial results, including a 75.84% revenue growth and a 96.55% earnings surprise in Q3 2025. The company's financial health is rated "GREAT" by InvestingPro analysts, reflecting investor confidence and robust growth.
Innovex International stock hits 52-week high at $24.32
Innovex International Inc. (INVX) stock reached a new 52-week high of $24.32, marking a 53.09% total return over the past year and a 42.64% price gain in the last six months. This surge follows strong Q3 2025 financial results, where the company significantly beat analyst expectations with an EPS of $0.57 and revenue of $240 million. InvestingPro analysts rate the company's financial health as "GREAT" with a P/E ratio of 17.58, suggesting fair valuation and highlighting investor confidence in its growth trajectory.
Innovex International (NYSE:INVX) Sets New 1-Year High - What's Next?
Innovex International (NYSE:INVX) shares hit a new 52-week high, trading as high as $24.34 on Monday. Wall Street sentiment is generally positive, with analysts like Piper Sandler raising price targets, and the stock holding a consensus "Buy" rating. The company boasts a strong financial position with a $1.64 billion market cap, low debt, and solid liquidity, and institutional investors have recently increased their stakes.
Innovex International stock hits 52-week high at $24.32 By Investing.com
Innovex International Inc.'s stock reached a new 52-week high of $24.32, reflecting a 53.09% total return over the past year and a 42.64% price gain in the last six months. This surge is attributed to robust growth, including a 75.84% revenue increase and strong Q3 2025 financial results which significantly beat analyst expectations. The company, with a $1.66 billion market cap and a "GREAT" financial health rating from InvestingPro, appears fairly valued at current levels.
Innovex International (NYSE:INVX) Is Reinvesting At Lower Rates Of Return
Innovex International's Return on Capital Employed (ROCE) has declined to 11% from 20% over the last three years, despite an increase in revenue and assets, suggesting the company is reinvesting for growth. While current returns are lower, the increased capital employed could lead to long-term benefits for shareholders. The stock has seen a 53% return over the past year, indicating investor confidence in the company's growth strategy.
Innovex International (INVX) Price Target Increased by $7, ‘Overweight’ Rating Maintained
Piper Sandler has increased its price target for Innovex International (INVX) from $20 to $27, maintaining an 'Overweight' rating, citing the company's resilience, market share growth, and strong free cash flow despite a challenging year for the energy industry. The revised target suggests over 22% upside potential, with analysts anticipating various tailwinds for the energy sector in 2026. Innovex International, formed in 2024, has shown significant share price growth of 52.38% since the beginning of 2025.
Innovex International (INVX) price target increased by $7, 'overweight' rating maintained
J.P. Morgan has increased its price target for Innovex International (INVX) by $7, despite a recent 16.9% drop in share price over the past month. The firm maintained its "overweight" rating, indicating continued confidence in the stock's future performance. This adjustment suggests that J.P. Morgan sees potential for recovery and growth in INVX, even after its recent market downturn.
Gabelli Funds LLC Lowers Stock Position in Innovex International, Inc. $INVX
Gabelli Funds LLC reduced its stake in Innovex International, Inc. (NYSE:INVX) by 15.3% in the second quarter, decreasing its holdings to 360,100 shares valued at $5.625 million. Despite this reduction, several other institutional investors increased their positions in INVX during the same period, including US Bancorp DE, First Horizon Advisors Inc., Smartleaf Asset Management LLC, PNC Financial Services Group Inc., and Police & Firemen s Retirement System of New Jersey. Innovex International's stock recently opened at $23.07, and the company has received a consensus "Buy" rating from analysts with an average target price of $16.50.
Gamco Investors INC. ET AL Sells 54,334 Shares of Innovex International, Inc. $INVX
Gamco Investors INC. ET AL sold 54,334 shares of Innovex International, Inc. (NYSE:INVX) during the second quarter, reducing its stake by 2.5% to 2,107,321 shares valued at approximately $32.92 million. Analyst sentiment for Innovex is improving, with Weiss Ratings upgrading the stock to "buy" and MarketBeat showing a consensus "Buy" rating with an average target price of $16.50. The company's stock opened at $23.38, near its 52-week high, and has a market capitalization of $1.61 billion.
Innovex International, Inc. $INVX Shares Sold by Fisher Asset Management LLC
Fisher Asset Management LLC reduced its stake in Innovex International ($INVX) by 55.8% in Q2, selling 171,207 shares and retaining 135,475 shares valued at $2.12 million. Despite this, other institutions like Wellington Management and Investment Management Associates significantly increased their holdings. Analysts maintain a "Buy" consensus rating for Innovex, with an average target price of $16.50, following a recent upgrade by Weiss Ratings.
We Think That There Are More Issues For Innovex International (NYSE:INVX) Than Just Sluggish Earnings
Innovex International's recent earnings were subdued, and while market reaction was minimal, underlying factors concerning unusual items warrant investor attention. A significant US$15m gain from unusual items suggests that the company's statutory profits might not accurately reflect its ongoing earning power, especially since such gains are often non-recurring. Coupled with a decrease in earnings per share over the last year, investors should consider these additional issues beyond just the reported earnings.
Innovex International (NYSE:INVX) Hits New 12-Month High - What's Next?
Innovex International (NYSE:INVX) reached a new 52-week high, trading at $23.38 with a significant intraday gain. Despite a "Moderate Buy" consensus from analysts, the current share price significantly exceeds their $16.50 target. The company demonstrates strong fundamentals, including a $1.62 billion market cap, a P/E of 15.94, and solid liquidity, yet recently reported a quarterly loss per share.
Innovex International stock reaches 52-week high at 23.12 USD
Innovex International Inc.'s stock hit a 52-week high of $23.12, reflecting a 46.78% increase over the past year and underscoring strong investor confidence. The company's financial health is rated "GREAT" by InvestingPro, with significant revenue growth and a healthy return on equity. This milestone follows a strong third-quarter 2025 earnings report where EPS and revenue significantly exceeded analyst expectations.
Brandes Investment Partners LP Boosts Position in Innovex International, Inc. $INVX
Brandes Investment Partners LP significantly increased its stake in Innovex International, Inc. (NYSE:INVX) by 7.7% in Q2, now owning 10.26% of the company, valued at $110.19 million. Despite a consensus "Moderate Buy" rating and a price target of $16.50, the stock is currently trading around $22.59, presenting a discrepancy between analyst targets and market price. Several other institutional investors also adjusted their positions, while the company's fundamentals show strong liquidity and low debt, alongside a recent quarterly loss.
How Barclays’ Upgrade and Key Partnerships at Innovex International (INVX) Have Changed Its Investment Story
Innovex International (INVX) received an upgrade from Barclays due to consistent free cash flow growth and strategic partnerships, including a new Saudi Arabian facility and an exclusive deal with OneSubsea. This follows its 2024 merger with Dril-Quip, strengthening its market position. The upgrade highlights Innovex's promising investment narrative but cautions investors about thin profit margins and board turnover.
Innovex Announces Third Quarter 2025 Results
Innovex International, Inc. announced strong financial results for the third quarter of 2025, with revenue up 7% quarter-over-quarter to $240 million and net income of $39 million. The company made significant progress on strategic initiatives, including closing the sale of its Eldridge facility for $90 million and signing an exclusive subsea wellhead provider agreement with OneSubsea. These moves are expected to drive market share gains, margin expansion, and build commercial momentum.
Innovex International, Inc. (NYSE:INVX) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Innovex International, Inc. (NYSE:INVX) has seen a 26% share price surge over the last 30 days, yet its P/E ratio of 15.1x remains lower than the market average, prompting further investigation. This low P/E is attributed to the company's receding earnings, including a 65% decrease last year and a 29% aggregate EPS shrinkage over the last three years, contrasting sharply with the market's predicted 16% growth. Therefore, despite the recent stock boost, the current P/E reflects investor concerns about future earnings performance and the company's struggle to maintain its current price.
Innovex International, Inc. (NYSE:INVX) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Innovex International's shares recently surged by 26%, contributing to a 36% gain over the past year. Despite this, its P/E ratio of 15.1x is low compared to the broader market, which the article attributes to the company's receding earnings, including a 65% decrease in the last year and a 29% decline over three years. The article suggests that while the stock has seen a boost, its low P/E is justified by its poor earnings performance and the expectation that it will underperform the market.
Innovex International stock hits 52-week high at 22.17 USD
Innovex International Inc. (INVX) stock has reached a new 52-week high of $22.17, driven by a 28.73% gain over the past year and a 46.24% year-to-date return. The company boasts a "GREAT" financial health score from InvestingPro, supported by strong revenue growth and a healthy current ratio. This performance reflects investor confidence, and the company recently surpassed analyst expectations for its third-quarter 2025 earnings.
Innovex International, Inc. Reveals Fall In Q3 Profit, But Beats Estimates
Innovex International, Inc. (INVX) reported a third-quarter profit of $39.22 million, or $0.57 per share, which is a decrease from $82.58 million, or $1.99 per share, in the previous year but still beat analyst estimates of $0.29 per share. The company's revenue for the period increased by 58.1% to $240.0 million from $151.81 million last year and they provided a next quarter revenue guidance of $235 - $245 million.
Innovex International, Inc. Announces Divestiture of the Dril-Quip Eldridge Campus - a Significant Business Transformation Milestone - and Provides Business Update
Innovex International, Inc. announced the divestiture of its Dril-Quip Eldridge Campus for $95.0 million, expected to close in Q3 2025, significantly bolstering its net cash position. This move is part of the company's transformation strategy, aiming to reduce operating footprint and enhance efficiency. Innovex also provided a Q1 2025 business update, revising revenue guidance downwards but maintaining strong Adjusted EBITDA expectations.
Oil Drilling Equipment Manufacturer Sells 1.3M SF Houston Industrial Property
Brennan Investment Group and PCCP have formed a joint venture to acquire a 1.3M SF, 16-building industrial portfolio in Northwest Houston for $90M from Innovex International Inc. The property, formerly Dril-Quip's headquarters, was sold with a lease-back agreement for Innovex while it completes consolidation. This marks the first partnership between Chicago-based Brennan Investment Group and Los Angeles-based PCCP.
Innovex sells Houston facility for $90 million in consolidation move
Innovex International, Inc. has sold its Houston facility for $90 million, generating $86.5 million in net proceeds. This move is part of the company's consolidation efforts, aiming to lower costs, simplify operations, and drive efficiencies. Innovex, formed by a 2024 merger, will lease back the property temporarily while considering options for the capital, such as acquisitions or share repurchases.
Innovex International, Inc. (INVX): A Bull Case Theory
This article summarizes a bullish thesis on Innovex International, Inc. (INVX), a Houston-based provider of engineered products for the oil and gas industry. The thesis highlights Innovex's capital-light model, recurring revenue from consumables, international expansion via the Dril-Quip merger, and potential for multiple expansion. Despite near-term headwinds, the company's long-term prospects are supported by disciplined capital allocation and innovation in its product offerings.
Innovex International (NYSE:INVX) Has A Rock Solid Balance Sheet
Innovex International (NYSE:INVX) holds a strong financial position, highlighted by US$47.9m in net cash as of June 2025. The company's liquid assets significantly exceed its total liabilities, suggesting it can easily manage its debt obligations. Furthermore, Innovex International's ability to convert 79% of its EBIT into free cash flow underscores its financial health and capacity to pay down debt.
Innovex Announces Second Quarter 2025 Results
Innovex International, Inc. announced its second-quarter 2025 financial results, highlighting a diversified portfolio and strong Free Cash Flow despite a 7% revenue decrease quarter-over-quarter to $224 million. The company achieved a net income of $15 million and an Adjusted EBITDA of $47 million, benefiting from the acquisition of Citadel Casing Solutions and strategic share repurchases. Innovex forecasts total revenue between $230-$240 million and an Adjusted EBITDA of $40-$45 million for the third quarter of 2025.
Innovex Announces First Quarter 2025 Results
Innovex International, Inc. announced its financial and operating results for the first quarter of 2025, reporting $240 million in revenue, a net income of $15 million, and adjusted EBITDA of $46 million. The company highlighted strategic progress including the expected sale of the Eldridge facility for $95 million and the repurchase of over 395,000 shares. Looking ahead, Innovex anticipates Q2 2025 revenues between $225-$235 million, driven by continued market share gains in North America despite softness in Mexico.
Innovex International, Inc. (NYSE:INVX) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Innovex International, Inc. (NYSE:INVX) has seen a 28% drop in its share price, leading to a low P/E ratio of 6.6x, significantly below the market average. Despite strong recent earnings growth of 18% in the last year and 200% over three years, investors seem skeptical about the company's ability to maintain these rates. This presents a potential opportunity for investors who believe the company's growth is sustainable, but it warrants careful scrutiny due to prevailing market doubt.
There May Be Underlying Issues With The Quality Of Innovex International's (NYSE:INVX) Earnings
Innovex International reported strong earnings, but a significant portion came from unusual items, raising concerns about the sustainability of its underlying profitability. While the market reacted positively to the earnings, shareholders should consider that these unusual gains are unlikely to be repeated, making the statutory profit a potentially poor indicator of future earnings power. The article suggests focusing on other metrics like balance sheet strength and impressive EPS growth over the last three years to get a clearer picture of the company's performance.
